Cargando…
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19
The ongoing enigmatic COVID-19 outbreak, first reported from Wuhan, China, on last day of the year 2019, which has spread to 213 countries, territories/areas till 28th April 2020, threatens hundreds of thousands human souls. This devastating viral infection has stimulated the urgent development of v...
Autores principales: | Ojha, Rupal, Gupta, Nidhi, Naik, Biswajit, Singh, Satyendra, Verma, Vijay Kumar, Prusty, Dhaneswar, Prajapati, Vijay Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224663/ https://www.ncbi.nlm.nih.gov/pubmed/32417398 http://dx.doi.org/10.1016/j.ejps.2020.105375 |
Ejemplares similares
-
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
por: Naik, Biswajit, et al.
Publicado: (2020) -
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections
por: Ojha, Rupal, et al.
Publicado: (2023) -
Strategic Development of a Next-Generation Multi-Epitope
Vaccine To Prevent Nipah Virus Zoonotic Infection
por: Ojha, Rupal, et al.
Publicado: (2019) -
Translational vaccinomics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus
por: Singh, Satyendra, et al.
Publicado: (2023) -
Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study
por: Srivastava, Varshita, et al.
Publicado: (2023)